Prudent Man Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Prudent Man Advisors's BMY Position: Q3 2026 in Review
Prudent Man Advisors increased its Bristol-Myers Squibb (BMY) stake by 28% in Q3 2026, buying an estimated $213K and bringing the position to 15,464 shares worth $965K. The position accounts for 0.23% of the portfolio, ranked #87.
Prudent Man Advisors first reported a position in BMY in Q2 2022 and has held it in 18 quarters since. 2,231 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Prudent Man Advisors held 15,464 shares of Bristol-Myers Squibb worth $965K as of Q3 2026.
- Prudent Man Advisors bought 3,376 Bristol-Myers Squibb shares in Q3 2026, an estimated $213K.
- Bristol-Myers Squibb made up 0.23% of Prudent Man Advisors's portfolio in Q3 2026, its #87 holding.
- Prudent Man Advisors first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 18 quarters since.
- 2,231 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Prudent Man Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.